HealthQuill insulin
Novo Nordisk’s medicine has been approved by the US drug regulator for reducing the risk of kidney failure and death due to cardiovascular disease in diabetic adults with chronic kidney disease.
Drugs Health Medical

Novo’ Nordisk’s drug to cut kidney disease advance in diabetics gets nod

Novo Nordisk’s medicine has been approved by the US drug regulator for reducing the risk of kidney failure and death due to cardiovascular.

Read More
Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients 18 years or older, to the treatment regime.
Drugs Health Pharma

Regulator okays Insulet’s insulin pump in US to treat type 2 diabetes

Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients.

Read More
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs Health Medical

New drug therapy boosts insulin production by 700% in diabetic mice

HQ  Team July 16, 2024: A new animal study has found a new therapy that is able to boost inuslin-producing cells by 700%.

Read More
US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side effects.
Drugs Health Pharma

Viking Therapeutics’ weight-loss drug shows ‘positive’ results in early trials

US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side.

Read More
A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is underway in US research institutions as the overall disease population is expected to reach 783 million people by 2045.
Drugs Health Medical

Hydrogel-based diabetes drug to cut need for insulin shots to thrice a year

HQ Team November 22, 2023: Stanford researchers have developed a promising hydrogel-based delivery system that will potentially transform diabetes treatment. This innovative technology,.

Read More
Drugs Health Medical

Novel long-acting GLP-1 agonist offers hope for type 2 diabetics

HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds.

Read More
A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is underway in US research institutions as the overall disease population is expected to reach 783 million people by 2045.
Drugs Health Medical Pharma

Type 4, and 5, diabetes in adults, children often misdiagnosed

HQ Team May 22, 2023: A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is.

Read More
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs Pharma

California sues insulin makers, PBMs, for skyrocketing prices

https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit

Read More
In overweight or obese people, a defect in an enzyme, APT1, interferes with the ability to secrete insulin resulting in Type 2 diabetes, according to a Washington University School of Medicine, St. Louis, study.
Drugs Pharma

Type 2 diabetes linked to an enzyme defect in obese people

In overweight or obese people, a defect in an enzyme, APT1, interferes with the ability to secrete insulin resulting in Type 2 diabetes,.

Read More
type2diabetes
Health Medical

Researchers find key cause of Type 2 diabetes and how to delay its progress

Researchers have found a potential way to slow down the decline in beta-cell function in Type 2 Diabetes

Read More